Skip to main navigation Skip to search Skip to main content

Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: A meta-analysis of randomized controlled trials

Fingerprint

Dive into the research topics of 'Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: A meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.

Cite this